 | Up a level |
Journal Article
Goede, V., Coutelle, O., Neuneier, J., Reinacher-Schick, A., Schnell, R., Koslowsky, T. C., Weihrauch, M. R., Cremer, B., Kashkar, H., Odenthal, M., Augustin, H. G., Schmiegel, W., Hallek, M. and Hacker, U. T. (2010). Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br. J. Cancer, 103 (9). S. 1407 - 1415. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827
Weihrauch, M. R., Richly, H., von Bergwelt-Baildon, M. S., Hacker, U., Shimabukuro-Vornhagen, A., Nokay, B., Tschaika, M., Schmidt, M., Wittig, B. and Scheulen, M. E. (2010). Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - safety results of a clinical phase I study. EJC Suppl., 8 (7). S. 24 - 25. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1359-6349
Weihrauch, M. R., von Bergwelt-Baildon, M. S., Hacker, U., Richly, H., Holtick, U., Tschaika, M., Schmidt, M., Wittig, B., Nokay, B. and Scheulen, M. E. (2010). Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - clinical efficacy and immunological results of a phase I study. EJC Suppl., 8 (7). S. 23 - 25. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1359-6349